Contract Notice Detail

Summary Information


Base Total Price:	234,781.884150 Euro
Request Reference:	10E0318524
Request Name:	Aquisição de Medicamentos Exclusivos, ao Lab. Sanofi, para a ULSASI, para o ano 2024
Phase:	Tendering Phase
State:	Awarded
Description:	Aquisição de Medicamentos Exclusivos, ao Lab. Sanofi, para a ULSASI, para o ano 2024
Procedure Type:	VortalGOV - Direct Award (ECP)

Object of the Contract

Type of Contract:

Supplies Acquisition

Main Object CPV Main Category:

Ic19 Amadora 2700 Venteira Amadora Lisboa PORTUGAL

CPV Main Vocabulary

33600000-6 - Pharmaceutical products

CPV Supplementary Vocabulary

Additional Classifications List

Scheduling

Request online publishing date:	4/12/2024 10:32 AM (UTC +1 hour)
Due datetime for receiving replies:	4/17/2024 5:00 PM (UTC +1 hour)

Financial Settings

Define Warranties?

Contract Documents

Document Name	Description	Doc Classification
Anexo II.xlsx	Anexo II.xlsx	Additional Information	Download
Caderno_Encargos_10E0318524.pdf	Caderno_Encargos_10E0318524.pdf	Instruction to tenderers	Download
Convite_10E0318524.pdf	Convite_10E0318524.pdf	Instruction to tenderers	Download

Object of contract

This contract is subject to renewal?	No
The procurement is related to a project and/or programme financed by European Union funds?	No

Legal, economic, financial and technical information

The contract is reserved to sheltered workshops and economic operators aiming at the social and professional integration of disabled or disadvantaged persons?

Questionnaire

Vision

Secção

1.1

Articulado da Consulta

CódigoDescrição QtUnidade

1	DUPILUMAB SC 300MG/2ML SOL INJ CAN	330,000000	UN
2	DUPILUMAB SC 150MG/ML; 2ML SOL INJ SER	60,000000	UN
3	ADENOSINA IV 3MG/ML 10ML SOL INJ	40,000000	UN
4	AMISSULPRIDA ORAL 5MG/ML10ML SOL ORAL	400,000000	UN
5	CLOBAZAM, ORAL, 10MG, CMP	11 000,000000	UN
6	DILTIAZEM, ORAL, 60 MG, CMP	400,000000	UN
7	ESPIRAMICINA, ORAL, 1,5 MUI, COMP	150,000000	UN
8	ISONIAZIDA+RIFAMPICINA OR 150+300MG COMP	1 200,000000	UN
9	MILRINONA, IV, 1MG/ML; 10 ML, SOL INJ	150,000000	UN
10	PIRAZINAMIDA, ORAL, 500MG, CAP	12 000,000000	UN
11	RASBURICASE, IV, 1,5MG, PO SOL INJ	60,000000	UN
12	RASBURICASE, IV, 7,5MG, PO SOL INJ	30,000000	UN
13	RIFAMPICINA, 20MG/ML;60ML, SUSP ORAL	180,000000	UN
14	VALPROATO SODIO+AC VALPR 250MG GRAN ORAL	174,000000	UN
15	VIGABATRINA, ORAL, 500 MG, CMP	120,000000	UN

Totais(Os valores mostrados não incluem IVA)

Evaluation